Supernus Pharmaceuticals ...

NASDAQ: SUPN · Real-Time Price · USD
43.22
1.05 (2.49%)
At close: Aug 15, 2025, 12:41 PM

Supernus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
22.5M -11.83M 15.33M 38.5M 19.92M 124K 1.18M -15.98M -831K 16.95M 25.48M 1.75M 7.87M 25.62M 2.44M 21.56M 23.73M 5.69M
Depreciation & Amortization
21.32M 20.38M 18.84M 20.09M 20.71M 20.75M 21.68M 21.86M 20.73M 20.6M 20.85M 21.77M 21.56M 21.36M 12.71M 6.67M 6.62M 6.59M
Stock-Based Compensation
7.51M 8.07M 7.63M 7.67M 6.55M 5.9M 6.45M 7.92M 6.09M 6.31M 4.26M 4.99M 4.3M 4.03M 4.04M 4.03M 5.48M 4.37M
Other Working Capital
8.28M 8.8M -11.23M -7.75M 8.62M 5.43M -395K 34.05M -27.23M -9.57M 2.4M 13.94M 6.38M 6.42M 3.6M -36.9M 27.23M 2.18M
Other Non-Cash Items
10.39M 4.06M 7.8M 1.61M 58.96M 42.21M 24.15M 1.67M 6.9M 288K 1.8M 12.33M -1K -11.97M 5.32M 6.64M -4.52M 17.18M
Deferred Income Tax
-7.16M -3.99M -72K -6.47M -8.12M -5.48M -10.46M -9.27M -5.55M -435K -7.76M -2.51M -3.05M -13.01M -4.51M 1.57M 519K -2.56M
Change in Working Capital
11.49M 13.91M -5.13M -7.88M -2.9M 13.87M 1.97M 29.67M -46.2M 5.42M -17.07M -24.49M 39.03M -21.72M 28.77M -44.58M 14.45M 4.92M
Operating Cash Flow
58.53M 30.6M 44.41M 53.52M 35.62M 38.4M 44.96M 35.88M -18.87M 49.13M 27.56M 13.84M 71.12M 4.3M 48.76M -4.11M 46.27M 36.2M
Capital Expenditures
-455K -327K -213K -200K -64K -248K 36K -150K -159K -278K 861K -147K 576K -851K -40K -497K n/a -1.51M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 82.08M n/a n/a -310.74M n/a -950K n/a
Purchase of Investments
-140.56M -118.56M -145.41M -224.93M -123.98M -193.7M -101.62M n/a n/a n/a -66.33M -134.16M -108.44M -98.06M -3.94M -74.36M -114.21M -119.06M
Sales Maturities Of Investments
110.4M 156.2M 132.98M 148.11M 75.45M 142.32M 35.6M 34.78M 60.45M 240.06M 17.55M 52.08M 92.19M 28.93M 377.96M 68.7M 34.27M 49.58M
Other Investing Acitivies
n/a n/a n/a 9K -48.53M -51.38M n/a 34.78M 60.45M 240.06M -851K -82.08M -16.25M -69.14M 12.89M 453K -950K -453K
Investing Cash Flow
-30.61M 37.32M -12.64M -77.01M -48.59M -51.62M -65.98M 34.63M 60.3M 239.78M -48.77M -82.23M -15.68M -69.99M 76.13M -5.7M -80.89M -71.44M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a -480.86M 78.36M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.34M -23.44M -987K -387K -1K -1.34M -1.99M n/a -575K -445K n/a n/a n/a -22.9M -138.31M 1.32M n/a n/a
Financial Cash Flow
935K -21.4M 5.89M 3.08M 1.66M 1.57M 1.09M -230K -478.92M 80.17M 2.83M 6.46M 2.27M -22.03M -136.74M 1.32M 2.75M 2.25M
Net Cash Flow
28.86M 46.52M 37.66M -20.42M -11.31M -11.65M -19.93M 70.28M -437.49M 369.08M -18.37M -61.94M 57.71M -87.72M -11.85M -8.49M -31.87M -33M
Free Cash Flow
58.08M 30.27M 44.19M 53.32M 35.56M 38.15M 44.99M 35.73M -19.03M 48.85M 28.43M 13.69M 71.69M 3.45M 48.72M -4.61M 46.27M 34.69M